PRGO

Perrigo Company plc

Healthcare · $2.1B market cap

Verdict

Share price

$14.26

close of Oct 3, 2026

Fair value

$40.64

Sticker Price

Payback Price

$16.26

buy price

On Sale

PRGO is On Sale: at $14.26 it trades 12% below its buy price (Payback Price) of $16.26 and 65% below its fair value of $40.64. Business quality is limited: none of the 5 key numbers clears the 10% bar.

How we valued it

Dividend Discount Model. It has paid a dividend for 10+ years in a row, raised it most years, and yields over 2%. For a steady payer like this, the dividend is the best guide to value.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth5.4% a year✗
Equity per share growth8.9% a year✗
Sales growth6.1% a year✗
Free cash flow growth5.0% a year✗
Return on invested capital2.2%✗

Follow PRGO

Get notified when it reaches its buy price of $16.26. Free.

Create a free account

Insider activity

Since Jun 12, 2026: no open-market purchases and 31 other filings (stock awards, tax withholding and similar). Why purchases matter

Other filings

Ball David

EVP & CBDO · 2026-09-09

Option exercise

7,701 shares

Ball David

EVP & CBDO · 2026-09-09

Tax withholding

$40K

Ball David

EVP & CBDO · 2026-09-09

Option exercise

$110K

Khoury Roberto

EVP and President of CSCI · 2026-07-08

Option exercise

737 shares

Khoury Roberto

EVP and President of CSCI · 2026-07-08

Tax withholding

$4K

Show all 31 other filings

Khoury Roberto

EVP and President of CSCI · 2026-07-08

Option exercise

$8K

Winterman Matthew John

EVP, Supply, Ops, Strategy · 2026-07-08

Option exercise

1,843 shares

Winterman Matthew John

EVP, Supply, Ops, Strategy · 2026-07-08

Tax withholding

$86K

Winterman Matthew John

EVP, Supply, Ops, Strategy · 2026-07-08

Tax withholding

$10K

Winterman Matthew John

EVP, Supply, Ops, Strategy · 2026-07-08

Option exercise

$19K

Winterman Matthew John

EVP, Supply, Ops, Strategy · 2026-07-08

Option exercise

15,660 shares

Winterman Matthew John

EVP, Supply, Ops, Strategy · 2026-07-08

Option exercise

$165K

Lennox Abigail

EVP and CSO · 2026-07-08

Award

84,826 shares

Willis Robert

EVP & CHRO · 2026-07-08

Award

60,085 shares

Winterman Matthew John

EVP, Supply, Ops, Strategy · 2026-07-08

Award

70,688 shares

Atkinson Charles

EVP, General Counsel & Sec. · 2026-07-08

Award

123,704 shares

Ball David

EVP & CBDO · 2026-07-08

Award

70,688 shares

Khoury Roberto

EVP and President of CSCI · 2026-07-08

Award

113,101 shares

Bezerra Eduardo Guarita

EVP & Chief Financial Officer · 2026-07-08

Award

141,376 shares

Gajial Muhammad Omer

director · 2026-07-08

Award

14,964 shares

Amin Ahmed Salman

director · 2026-07-08

Award

14,964 shares

Manzone Albert

Interim President and CEO · 2026-07-08

Award

235,627 shares

Alford Bradley A

director · 2026-06-12

Option exercise

976 shares

Alford Bradley A

director · 2026-06-12

Award

2,559 shares

Alford Bradley A

director · 2026-06-12

Tax withholding

$5K

Alford Bradley A

director · 2026-06-12

Option exercise

$11K

Manzone Albert

Interim President and CEO · 2026-06-12

Award

1,069 shares

Parker Geoffrey M.

director · 2026-06-12

Option exercise

976 shares

Parker Geoffrey M.

director · 2026-06-12

Award

844 shares

Parker Geoffrey M.

director · 2026-06-12

Tax withholding

$5K

Parker Geoffrey M.

director · 2026-06-12

Option exercise

$11K

About Perrigo Company plc

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte…

Drug Manufacturers - Specialty & Generic

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works